Clinical Trials Browser

Phase 3 × OTHER × Fenretinide × Clear all

NCT00004154 2018-11-08

Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder Cancer

Phase 3 Completed

Urinary Bladder Neoplasms

NCT01479192 2018-11-07

Fenretinide in Healthy Young Women at Genetic and Familial Risk

Phase 3 Terminated

Neoplasms